Demonstrates wortmannin's anticancer effects in oral cancer, suggesting potential clinical applications.
The in-silico strategy used in this study establishes the framework for cancer therapeutic research. This research has revealed wortmannin's ability to treat oral cancer in clinical settings. To validate in-silico and in-vitro findings, more assays and in-vivo research are needed.
No takes yet. Share an insight, caveat, or question.
Kumbhar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: